Your browser doesn't support javascript.
loading
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage.
Agrez, Michael; Rybchyn, Mark Stephen; De Silva, Warusavithana Gunawardena Manori; Mason, Rebecca Sara; Chandler, Christopher; Piva, Terrence J; Thurecht, Kristofer; Fletcher, Nicholas; Liu, Feifei; Subramaniam, Gayathri; Howard, Christopher B; Blyth, Benjamin; Parker, Stephen; Turner, Darryl; Rzepecka, Justyna; Knox, Gavin; Nika, Anastasia; Hall, Andrew; Gooding, Hayley; Gallagher, Laura.
Afiliação
  • Agrez M; InterK Peptide Therapeutics Limited, Sydney, NSW, Australia. michael.agrez@interk.com.au.
  • Rybchyn MS; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia. michael.agrez@interk.com.au.
  • De Silva WGM; School of Medical Sciences and Bosch Institute, University of Sydney, Sydney, Australia.
  • Mason RS; School of Medical Sciences and Bosch Institute, University of Sydney, Sydney, Australia.
  • Chandler C; School of Medical Sciences and Bosch Institute, University of Sydney, Sydney, Australia.
  • Piva TJ; Charles Perkins Centre and School of Life and Environmental Sciences, University of Sydney, Sydney, Australia.
  • Thurecht K; Auspep Pty Limited, Melbourne, Australia.
  • Fletcher N; Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
  • Liu F; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.
  • Subramaniam G; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia.
  • Howard CB; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.
  • Blyth B; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia.
  • Parker S; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.
  • Turner D; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia.
  • Rzepecka J; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.
  • Knox G; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia.
  • Nika A; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.
  • Hall A; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia.
  • Gooding H; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology at the University of Melbourne, Melbourne, Australia.
  • Gallagher L; InterK Peptide Therapeutics Limited, Sydney, NSW, Australia.
Sci Rep ; 13(1): 11702, 2023 07 20.
Article em En | MEDLINE | ID: mdl-37474630

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália